Publicaciones en colaboración con investigadores/as de New York University School of Medicine (17)

2016

  1. Pragmatic assessment of exercise in routine care using an MDHAQ: Associations with changes in RAPID3 and other clinical variables

    Arthritis Research and Therapy, Vol. 18, Núm. 1

2015

  1. Routine assessment of patient index data (RAPID3) and bath ankylosing spondylitis disease activity index (BASDAI) scores yield similar information in 85 Korean patients with ankylosing spondylitis seen in usual clinical care

    Journal of Clinical Rheumatology, Vol. 21, Núm. 6, pp. 300-304

2014

  1. Discordance of global estimates by patients and their physicians in usual care of many rheumatic diseases: Association with 5 scores on a multidimensional health assessment questionnaire (MDHAQ) that are not found on the health assessment questionnaire (HAQ)

    Arthritis Care and Research, Vol. 66, Núm. 6, pp. 934-942

  2. Índices compuestos para evaluar la actividad de la enfermedad y el daño estructural en pacientes con lupus eritematoso: Revisión sistemática de la literatura

    Reumatologia Clinica

2013

  1. Assessing remission in rheumatoid arthritis on the basis of patient reported outcomes: Advantages of using RAPID3/MDHAQ in routine care

    Bulletin of the Hospital for Joint Diseases, Vol. 72, Núm. 2, pp. 136-141

  2. Documenting the value of care for rheumatoid arthritis, analogous to hypertension, diabetes, and hyperlipidemia: Is control of individual patient self-report measures of global estimate and physical function more valuable than laboratory tests, radiographs, indices, or remission criteria?

    Journal of Rheumatology

  3. Efficacy and safety of methotrexate in combination with other Non-Biologic diseasemodifying antirheumatic drugs (DMARDs) in treatment of rheumatoid arthritis

    Bulletin of the Hospital for Joint Diseases, Vol. 71, pp. S20-S28

  4. Evidence that the strategy is more important than the agent to treat rheumatoid arthritis: Data from clinical trials of combinations of non-biologic dmards, with Protocol-Driven intensification of therapy for tight control or Treat-To-Target

    Bulletin of the Hospital for Joint Diseases, Vol. 71, pp. S33-S40

  5. GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate

    Rheumatology (United Kingdom), Vol. 52, Núm. 10, pp. 1890-1897

  6. RHEUMDOC: A one-page RHEUMatology DOCtor form with four physician global estimates for overall status, inflammation, damage, and symptoms based on neither inflammation nor damage

    Bulletin of the Hospital for Joint Diseases, Vol. 72, Núm. 2, pp. 142-147

  7. Update on methotrexate as the anchor drug for rheumatoid arthritis

    Bulletin of the Hospital for Joint Diseases, Vol. 71, pp. S9-S19

2012

  1. Effective initial and long-term prednisone in doses of less than 5 mg/day to treat rheumatoid arthritis documentation using a patient self-report multidimensional health assessment questionnaire (MDHAQ)

    Bulletin of the NYU Hospital for Joint Diseases, Vol. 70, Núm. SUPPL. 1

  2. MDHAQ/RAPID3 can provide a roadmap or agenda for all rheumatology visits when the entire MDHAQ is completed at all patient visits and reviewed by the doctor before the encounter

    Bulletin of the NYU Hospital for Joint Diseases, Vol. 70, Núm. 3, pp. 177-186

  3. Pragmatic and scientific advantages of MDHAQ/ RAPID3 completion by all patients at all visits in routine clinical care

    Bulletin of the NYU Hospital for Joint Diseases, Vol. 70, Núm. SUPPL. 1

2011

  1. Association between myasthaenia gravis and systemic lupus erythematosus: Three case reports and review of the literature

    Scandinavian Journal of Rheumatology, Vol. 40, Núm. 6, pp. 486-490

  2. MDHAQ/RAPID3 scores quantitative patient history data in a standardized "scientific" format for optimal assessment of patient status and quality of care in rheumatic diseases

    Bulletin of the NYU Hospital for Joint Diseases, Vol. 69, Núm. 3, pp. 201-214

  3. Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: A patient multidimensional health assessment questionnaire and physician estimate of noninflammatory symptoms

    Journal of Rheumatology, Vol. 38, Núm. 7, pp. 1309-1316